Knowledge base · Peer-reviewed

ScaleWiki.

Peer-reviewed manuscripts on the G-Rex® platform — one citable page per paper, curated so you find the evidence that moves your cell & gene therapy program forward.

487Manuscripts indexed
14Cell types
Live indexContinuously updated

Showing 12 of 530 resources

Publications VST Cells G-Rex®24 Well Plate

Publication Date: January 30, 2024

T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma

Virus-positive Merkel cell carcinoma patients who responded to PD-1 blockade showed a broader and larger T antigen–specific CD8+ T cell response in blood than nonresponders. Using DNA-barcoded pMHC multimers covering 33 HLA class I haplotypes, the authors screened 26 patients treated with pembrolizumab and detected T cell recognition of 32 T antigen epitopes, 20 previously unreported. Responders (n = 17) gained more T antigen–specific populations after treatment than nonresponders (n = 7). In a second cohort of 19 patients, antigen-presenting scaffolds expanded T antigen–specific T cells in 13 patients, with an average 214-fold increase over 14 days. Expanded cells killed HLA-matched Merk…

Download Now →

Author: Ulla Kring Hansen, Candice D. Church +10 more

Publications CAR T Cells

Publication Date: January 26, 2024

Geometric parameters that affect the behavior of logic-gated CAR T cells

In the Tmod two-receptor system, blocker function depends on the height of the blocker antigen above the target cell membrane, and receptor hinge length can compensate for mismatched antigen pairs. Jurkat cells carrying a CD19 activator were inhibited approximately 90% by an HLA-A*02 blocker (55Å), but only 40% by a mesothelin blocker (90Å) and 20% by an ICAM-1 blocker (185Å). Blockers against membrane-proximal mesothelin epitopes inhibited more strongly than membrane-distal ones (Imax ~70% vs 50%; IC50 ~60 ng vs 250 ng mRNA). Using EGF-like hinge repeats, long activators paired with short blockers gave the best selectivity, and primary T cells in that configuration completely spared CD19…

Download Now →

Author: Alexander C. Partin, Richele Bruno +11 more

Publications CAR T Cells

Publication Date: January 25, 2024

Inosine Induces Stemness Features in CAR-T cells and Enhances Potency

Adding inosine to culture medium during manufacturing gave human CAR-T cells a stem-like, more potent profile, whereas knocking out CD39, CD73 or the adenosine receptor A2aR changed them only modestly. Overexpressing adenosine deaminase, which converts adenosine to inosine, shifted exhausted GD2 CAR-T cells toward stem-like memory states, and inosine alone reproduced this in vitro with higher CD62L, greater cytokine release and cytotoxicity. Inosine lowered glycolysis, raised glutaminolysis and polyamine synthesis, increased chromatin accessibility at stemness genes, and its stemness effect was lost after EIF5A knockout. In a clinical-scale GD2-CAR run in a semi-closed G-Rex® system, inos…

Download Now →

Author: Dorota D. Klysz, Carley Fowler +25 more

Publications CAR T Cells, DC Cells, TIL Cells

Publication Date: January 15, 2024

Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy

Autologous cell therapies for cancer fall into four classes: CAR T cells, tumor-infiltrating lymphocytes, dendritic cell vaccines and whole tumor cell vaccines. Each class faces distinct engineering hurdles. CAR T cells need efficient, multiplexed gene editing and more consistent products, while TIL therapy needs simpler, faster manufacturing and less exhaustion. DC vaccines require better cell sources, antigen loading and lymph node trafficking, and tumor cell vaccines need wider patient eligibility and consistent genetic modification. Across all four, the review identifies long manufacturing times, specialized expansion processes, quality control, trafficking, and toxicity from cytokine…

Download Now →

Author: Colleen R Foley, Sheridan L Swan +1 more

Publications Treg Cells G-Rex®24 Well Plate

Publication Date: January 8, 2024

Therapeutic Effects of Aβ-Specific Regulatory T Cells in Alzheimer’s Disease: A Study in 5xFAD Mice

Ex vivo-expanded, amyloid-β-specific regulatory T cells improved memory and reduced Alzheimer's-type pathology in 5xFAD mice, with benefits at doses as low as 1.5 × 10^3 cells per mouse. Splenocytes from C57BL/6 mice, depleted of CD8 cells, were exposed for four days to fibrillized Aβ and bee venom phospholipase A2; CD4+CD25+ Tregs were then isolated at over 97% purity and expanded for two weeks in a G-Rex® 24-well plate with CD3/CD28 beads and 2000 U/mL IL-2. Eight weeks after intravenous transfer, treated mice showed better Y-maze alternation and passive-avoidance latency, less hippocampal Aβ, phosphorylated tau and NOS2, lower pro-inflammatory transcripts and a stronger anti-inflammato…

Download Now →

Author: Seon-Young Park, Juwon Yang +4 more

Publications VST Cells G-Rex®5M

Publication Date: December 22, 2023

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay

A vital dye-based flow cytometric assay detected the cytolytic activity of multivirus-specific T cells far more reliably than the standard chromium-51 release assay. The cells target five viruses (AdV, BKV, CMV, EBV, HHV6). In seven donors, the 16-hour CFSE assay at a 40:1 effector:target ratio measured specific lysis of at least three to all five viruses, with mean lysis of 9.3% to 28.4%. The 5-hour chromium assay gave heterogeneous, mostly lower values. Sorted CD4+ T cells also killed all five viral targets in the CFSE assay but not in the chromium assay. Optimal co-culture lasted 16 hours, and no non-specific killing of irrelevant or allogeneic targets was seen. PKH26 dye and different…

Download Now →

Author: Kiriakos Koukoulias, Penelope G. Papayanni +8 more

Publications CAR T Cells

Publication Date: December 18, 2023

The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation

Anti-mesothelin SS1 CAR T-cells carrying a 4-1BBζ endodomain responded more strongly than untransduced T-cells when stimulated through their endogenous T-cell receptor. Retrovirally transduced products from three healthy donors, expanded for 13 days in G-Rex® plates, were compared with untransduced cells and with a signalling-dead zeta-mutant control. After staphylococcal enterotoxin B stimulation, CD8+ 4-1BBζ cells reached a division index of 1.3 versus 0.4 for untransduced cells, 17.4% IFNγ-positive cells versus 6.0%, and 83.4% CD69-positive cells versus 45.2%. Pervanadate-stimulated CD8+ 4-1BBζ cells showed higher phosphorylated ZAP70 (MFI 3104 versus 1643), and their central memory fr…

Download Now →

Author: Gerard J. Chu, Charles G. Bailey +4 more

Publications CAR T Cells G-Rex®24 Well Plate, G-Rex®6 Well Plate

Publication Date: December 14, 2023

HER2 and HLA- A*02 dual CAR- T cells utilize LOH in a NOT logic gate to address on- target off- tumor toxicity

A dual CAR-T cell pairing a trastuzumab-derived HER2 activating CAR with an inhibitory CAR carrying a LIR1 signaling domain killed HLA-A*02-negative lung cancer cells while sparing their isogenic HLA-A*02-positive counterparts. Screening primary T cells against H1703 targets identified the LIR1 inhibitory domain as the most effective regulator of the activating CAR. Removing the LIR1 D1-D4 Ig motifs raised protection about eightfold, a 30 amino acid hinge proved optimal, and a fully human anti-A2 antibody added about threefold more; protection required both A2 binding and LIR1 signaling. In NSG mice an optimized hinge, humanized or fully human scFv and an IRES linker allowed efficient pro…

Download Now →

Author: David Bassan, Leehee Weinberger +15 more

Publications CAR T Cells, TCR T Cells G-Rex®24 Well Plate

Publication Date: December 13, 2023

Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair

Homology-mediated end-joining (HMEJ) enabled Cas9-directed non-viral knock-in of DNA cargo ranging from 1 kb to 6.7 kb into primary human T cells at rates of up to 70% with post-editing viability above 80%. Electroporating the cells 36 hours after CD3/CD28 bead activation, a window named the goldilocks zone, raised integration to 25.7% ±3.5 compared with 5.33% ±1.59 at 24 hours. For a roughly 3 kb transgenic TCR cassette, linearised donor vectors carrying 48 bp homology arms reached 31.35% ±6.12 against 8.40% ±1.76 for homologous recombination. A 6.3 kb five-gene construct yielded 20.1% ±3.43 CD19 CAR-positive cells, rising to 70.3% ±8.66 after methotrexate selection, and these CAR T cell…

Download Now →

Author: Beau R. Webber, Matthew J. Johnson +14 more

Publications CAR T Cells, T-Cells G-Rex®6 Well Plate

Publication Date: November 30, 2023

Modular chimaeric cytokine receptors with leucine zipper enhance the antitumor activity of CAR T cells via JAK/STAT signalling

Replacing the extracellular domains of heterodimeric cytokine receptors with leucine zipper motifs produced constitutively active chimeric receptors (ZipRs) that signal without exogenous cytokine. Two zipper motifs were required: Zip2R(2x) drove higher STAT5 phosphorylation, formed larger receptor clusters and kept T cells alive through 7 to 21 days of cytokine starvation, while a single motif did not, and neither construct triggered autonomous growth over 60 days of culture. Zip2R and Zip7R improved B7-H3-CAR and EphA2-CAR T cell expansion and killing across repeated weekly tumor stimulations. In mice bearing intravenous A549 lung tumors, a single subtherapeutic dose of 3 x 10^5 B7-H3-CA…

Download Now →

Author: Matthew Bell, Shannon Lange +25 more

Publications CAR T Cells G-Rex®100M, G-Rex®6M Well Plate

Publication Date: November 29, 2023

Technological and Manufacturing Innovation Drive Improved Access to Engineered T Cell Therapies

A low-cost, point-of-care CAR-T workflow was built around negative T cell selection by red blood cell rosetting, activation, lentiviral transduction and static expansion in G-Rex® vessels. Rosetting of whole blood or quarter leukopak material yielded more than 1 × 10^8 T cells in every donor. Tri-specific CD19/CD20/CD22 CAR-T cells transduced at an MOI of 40 expanded about 35-fold by day 8 in G-Rex®, and replacing the day 3 wash with a 10-fold medium increase did not impair expansion, viability, phenotype or cytotoxicity. Products were dominated by stem-cell memory cells. Scale-up used 1 × 10^8 T cells in a G-Rex® 100M.

Download Now →

Author: Ying Xiong, Yanping Xie +5 more

Publications CAR T Cells

Publication Date: November 20, 2023

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

A bispecific CD33/CD123 CAR built as an AND logic gate controlled acute myeloid leukemia in mice as well as monospecific CD33 or CD123 CARs, while proving less cytotoxic to CD34+ stem cells. Five de novo anti-CD33 and eight anti-CD123 scFv constructs were first screened against engineered CHO target cells, then 32 double-transduced pairings were compared, and 12 single-construct bispecific CARs were built, of which CAR 1 was selected on cytotoxicity, cytokine release and binding avidity. NSG mice bearing 5 × 10^5 MV411 cells received 1 × 10^6 CAR T cells, with no significant survival difference between CAR groups. In humanized CD34+ mice, body weight and blood counts were unchanged, and c…

Download Now →

Author: Justin C. Boucher, Bishwas Shrestha +11 more